Cargando…

Medicinal nicotine in COVID-19 acute respiratory distress syndrome, the new corticosteroid

The cholinergic anti-inflammatory pathway (CAP) refers to the anti-inflammatory effects mediated by the parasympathetic nervous system. Existence of this pathway was first demonstrated when acetylcholinesterase inhibitors showed benefits in animal models of sepsis. CAP functions via the vagus nerve....

Descripción completa

Detalles Bibliográficos
Autor principal:	Ahmad, Farrukh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305679/ https://www.ncbi.nlm.nih.gov/pubmed/36051943 http://dx.doi.org/10.5492/wjccm.v11.i4.228

Ejemplares similares

Acute cor pulmonale in patients with acute respiratory distress syndrome: A comprehensive review
por: See, Kay Choong
Publicado: (2021)

Antenatal corticosteroids in COVID-19 perspective
por: Vidaeff, Alex C, et al.
Publicado: (2021)

Extracorporeal membrane oxygenation and inhaled sedation in coronavirus disease 2019-related acute respiratory distress syndrome
por: Bellgardt, Martin, et al.
Publicado: (2021)

Corticosteroids in acute respiratory distress syndrome: outcomes obscured by mortality
por: Oh, Dong Kyu
Publicado: (2021)

Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19
por: Goursaud, Suzanne, et al.
Publicado: (2020)

COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome
por: Vidal-Cortés, Pablo, et al.
Publicado: (2020)

Acute-on-chronic liver failure in patients with severe acute respiratory syndrome coronavirus 2 infection
por: Liptak, Peter, et al.
Publicado: (2023)

Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far
por: Anirvan, Prajna, et al.
Publicado: (2020)

Treatment of eosinophlic esophagitis with swallowed topical corticosteroids
por: Nennstiel, Simon, et al.
Publicado: (2020)

Use of corticosteroids in COVID-19 patients vs. acute respiratory distress syndrome of other etiologies: Are there any differences?
por: Barrera-López, Pedro, et al.
Publicado: (2021)

COVID-19–related Acute Respiratory Distress Syndrome Subphenotypes and Differential Response to Corticosteroids: Time for More Precision?
por: Reddy, Kiran, et al.
Publicado: (2021)

Do we know enough to recommend corticosteroids in acute respiratory distress syndrome?
por: Blot, Mathieu, et al.
Publicado: (2017)

Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options
por: Khan, Suliman, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 may cause liver injury via Na(+)/H(+) exchanger
por: Cumhur Cure, Medine, et al.
Publicado: (2023)

Non-pulmonary involvement in COVID-19: A systemic disease rather than a pure respiratory infection
por: El-Kassas, Mohamed, et al.
Publicado: (2023)

Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids
por: Sinha, Pratik, et al.
Publicado: (2021)

Healthcare practice strategies for integrating personalized medicine: Management of COVID-19
por: Liu, Wen-Yi, et al.
Publicado: (2021)

Acute Respiratory Distress Syndrome
por: Ahmad, Fawaz, et al.
Publicado: (2018)

Overview: Replication of porcine reproductive and respiratory syndrome virus
por: Yun, Sang-Im, et al.
Publicado: (2013)

Issues related to post-COVID-19 syndrome
por: Özdemir, Öner, et al.
Publicado: (2022)

Impact of inhaled and intranasal corticosteroids on glucose metabolism and diabetes mellitus: A mini review
por: See, Kay Choong
Publicado: (2023)

Sources, Components, Structure, Catalytic Mechanism and Applications: a Critical Review on Nicotinate Dehydrogenase
por: Chen, Zhi, et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus 2 pandemic related morbidity and mortality in patients with pediatric surgical diseases: A concerning challenge
por: Vaos, George, et al.
Publicado: (2022)

Medicinal cannabis products for the treatment of acute pain
por: Fiore, Marco, et al.
Publicado: (2023)

In Defense of Evidence-based Medicine for the Treatment of COVID-19 Acute Respiratory Distress Syndrome
por: Rice, Todd W., et al.
Publicado: (2020)

Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome
por: Segú-Vergés, Cristina, et al.
Publicado: (2023)

Acute kidney injury and electrolyte disorders in COVID-19
por: Nogueira, Gabriel Martins, et al.
Publicado: (2022)

Surgical intervention for acute pancreatitis in the COVID-19 era
por: Su, Yu-Jang, et al.
Publicado: (2022)

Corticosteroid Administration Is Associated With Improved Outcome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2-Related Acute Respiratory Distress Syndrome
por: Chopra, Amit, et al.
Publicado: (2020)

Understanding COVID-19 Acute Respiratory Distress Syndrome
por: Singh, Anchit Raj, et al.
Publicado: (2022)

Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019
por: Villar, Jesús, et al.
Publicado: (2020)

Advancing precision medicine for acute respiratory distress syndrome
por: Beitler, Jeremy R, et al.
Publicado: (2022)

Phenotypes and personalized medicine in the acute respiratory distress syndrome
por: Matthay, Michael A., et al.
Publicado: (2020)

Interferon-lambda: New role in intestinal symptoms of COVID-19
por: Pan, Yi-Yang, et al.
Publicado: (2023)

A Comparison of Inhaled Epoprostenol in Patients With Acute Respiratory Distress Syndrome and COVID-19-Associated Acute Respiratory Distress Syndrome
por: Robinson, John, et al.
Publicado: (2022)

COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review)
por: Krynytska, Inna, et al.
Publicado: (2021)

The effectiveness of Corticosteroids on mortality in patients with acute respiratory distress syndrome or acute lung injury: a secondary analysis
por: Zhang, Zhongheng, et al.
Publicado: (2015)

COVID-19 and liver dysfunction in children: Current views and new hypotheses
por: Yun, Yang-Fang, et al.
Publicado: (2023)

Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
por: Ilias, Ioannis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sd5m27hhcrq8hm0jv9h4i80qur